Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Jubilant Life Sciences...

    Jubilant Life Sciences arm expands drug discovery services biz in Greater Noida, Bengaluru

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-12-02T15:35:44+05:30  |  Updated On 2 Dec 2019 3:35 PM IST

    Due to growing customer demand for its range of functional and integrated drug discovery services, Jubilant Biosys(Bengaluru-based subsidiary of Jubilant Life Sciences Ltd.) has started design and construction of brand new and state-of-the-art chemistry services laboratories on the existing Jubilant Greater Noida site.


    New Delhi: Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Lifesciences Limited, recently announced the commencement of two expansion projects in Greater Noida and Bengaluru.


    Due to growing customer demand for its range of functional and integrated drug discovery services, Jubilant Biosys has started design and construction of brand new and state-of-the-art chemistry services laboratories on the existing Jubilant Greater Noida site.


    The chemistry FTE capacity will be doubled and operations are expected to commence from H2 2020. The new site can accommodate up to 500 Chemistry FTE’s. The site will be designed for the highest global compliance standards and deliver superior speed and quality in the entire drug discovery process.


    In Bengaluru, Jubilant Biosys has obtained a 10-acre plot in the Devanahalli Industrial Park which is adjacent to the International Airport. A completely new drug discovery services site will be constructed in phases for further expansions.


    In addition, the company has formed a new digital business unit comprising of Bio-Informatics, Data-curation for AI/ML, TrialStat EDC software as well as discovery focussed AI/ML capabilities. This business unit will also further expand on the new site and deliver increased benefits to our customers.


    Read Also: Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh


    Marcel Velterop, President – Jubilant Biosys and CDMO, said, “The improving customer confidence earned through exemplary scientific execution and a positive outlook in the global drug discovery industry has resulted in the largest investment program in Jubilant Biosys since its inception. We will soon be able to offer our customers much-improved capacity and services as well as an ability to deliver an integrated IND package along with superior functional discovery services."


    "A combination of the best talent and the state-of-the art technology and instrumentation will be offered to pursue drug discovery collaborations and help deliver new innovation to patients faster than ever, ” he added.


    Read Also: Jubilant Life Sciences appoints Alok Vaish as CFO, Key Managerial Personnel

    Bengaluru facilityCDMOchem services labsDevanahalli Industrial Parkdrug discoveryFTE capacityGreater NodiaGrenoJubilantJUBILANT BIOSYSJubilant LifeJubilant Life SciencesMarcel Velteroppharmapharma newspharma news india

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok